Site Index
Home
Company Overview
Company History
Business Strategy
Management
Board of Directors
Scientific & Medical Advisors
Therapeutic Focus
Pain
Inflammatory Bowel Disease
Development Pipeline
Topical Diclofenac
Simulect
Investors
Press Releases
Company History
Management Team
Board of Directors
News & Events
Careers
Contact
Privacy Policy
Terms of Use
Site Index
Company Overview
Company History
Business Strategy
Management Team
Board of Directors
Scientific & Medical Advisors
Therapeutic Focus
Pain
Inflammatory Bowel Disease
Development Pipeline
Topical Diclofenac
Simulect®
Investors
Press Releases
Company History
Management Team
Board of Directors
News
Careers
RECENT NEWS
Cerimon to Conduct a Proof of Concept Study for Basiliximab for Noninfectious Uveitis, a Potentially Sight-Threatening Inflammation of the Eye
March 10, 2008
Cerimon Pharmaceuticals Initiates Phase II/III Clinical Studies to Evaluate Its Diclofenac Patch for Mild to Moderate Pain
January 16, 2008
Cerimon Pharmaceuticals Names Matthew J. Meyer its General Counsel and Vice President of Business Development and Licensing
January 4, 2008
